Skip to main content

TAU Student, COVID-19 Sprint Invent Disposable Ventilators to Help Treat Coronavirus Patients

Written on |

TAU Student, COVID-19 Sprint Invent Disposable Ventilators to Help Treat Coronavirus Patients

Israel’s Health Ministry has approved the use of a prototype in a pilot study Together with COVID-19 Sprint, a technology task force led by Assuta Ashdod Hospital, Rafael Advanced Technology and Weizmann Institute of Science, a doctoral student at Tel Aviv University‘s Iby and Aladar Fleischman Faculty of Engineering is helping to develop an inexpensive disposable ventilator specifically tailored to treat COVID-19 patients. It’s called MANSHEMA, is cheap, suitable for mass production and easy to use, and Israel’s Health Ministry recently approved the use of its prototype in a pilot study. “Around the world, hospitals overwhelmed with COVID-19 patients are experiencing a shortage of ventilators,” explains Stav Bar-Sheshet, a doctoral student of engineering engaged in research for the project. “This is a serious crisis, which requires creative and revolutionary thinking, thinking that will result in the efficient, fast and cheap solutions.” The idea, he says, is to produce a cheap, disposable ventilator from existing parts that are widely available. While MANSHEMA is disposable, it can work nonstop for three months at a stretch. Most critically for the novel coronavirus, the cheaply produced ventilator is tossed out after each use, drastically reducing the risk of infection by medical staff and hospital patients. “Coronary disease is highly contagious,” adds Bar-Sheshet. “The unique idea of the disposable respirator is that after being used on one patient, it will be destroyed and a new ventilator applied to a subsequent patient.” MANSHEMA is a flow driven, electronically controlled system that allows the patient to determine his or her own respiratory rate and to alert of malfunctions and respiratory failures. The system assists the patient to breath by providing what’s called Bi-level Positive Pressure, meaning the system maintains a positive pressure at all times to assist in cases of respiratory distress. Both exhalation and inhalation pressures can be adjusted by both the patient and medical staff. The system is noninvasive and particularly suited to low to moderate risk patients. “An electrically-controlled-mechanical-valve opens and closes the exhaust to allow real-time inhale and exhale,” says Bar-Sheshet. “If the patient stops breathing, alerts are triggered and the system automatically enters a mandatory respiration mode.” In a spirit of friendly competition, COVID-19 Sprint has set up two to three teams for each challenge. Each team contains a core group of builders (product manager, engineers, solution architects), with a clinical advisory group advising each challenge. Volunteers with experience as engineers, product managers, clinicians, care managers, project managers are welcome to join existing teams or create new teams. “To date, the team, with the support of the Health Ministry, have a few prototypes tested by medical staff at Assuta Ashdod Hospital,” concludes Bar-Sheshet. “The Health Ministry helped us meet Helsinki requirements that will now allow us to proceed to a clinical trial on patients with respiratory problems and on COVID-19 patients.”

Related posts

Will Existing Drugs Stop Cancer’s Bone Spread?

19 May 2024

Heart Disease’s Cancer Link Unveiled

14 April 2024

Do Green Environments Help Heart Patients Live Longer?

4 April 2024

TAU Receives $12.67M Grant for Medical Simulation Center

1 April 2024

Breaking the MedTech Glass Ceiling

27 March 2024

Summer Glow: How Sun Exposure Boosts Fertility in Women Ages 30-40

7 March 2024

Are We Close to Ending Alzheimer’s Memory Loss?

15 February 2024

Destroying Cancer: new drug delivery system containing RNA therapy can target cancer cells in bone marrow

31 July 2023

Stress Makes Vaccines Less Effective

26 July 2023

Researchers Induce Cancer Cell “Suicide”

17 July 2023

Metabolomics – A New Frontier in Preventive Medicine

13 July 2023

Older Bats do Suffer from Age-related Hearing Loss

13 July 2023

Operation Guardian of the Walls: Women, Young People and Residents of the South Paid the Heaviest Price

12 July 2023

Discovery May Lead to Personalized Medicine for Infectious Diseases

12 July 2023

One Third of Normal-Weight Individuals are Obese

12 July 2023

Breakthrough Gene Therapy Offers Hope for Severe Developmental Epilepsy in Children

27 June 2023


Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: [email protected]

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: [email protected]

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: [email protected]